Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
70.29 USD | +1.93% | +4.79% | -4.48% |
May. 17 | Nuvalent Insider Sold Shares Worth $345,450, According to a Recent SEC Filing | MT |
May. 16 | Nuvalent Gets FDA Breakthrough Therapy Designation for Lung-Cancer Treatment | DJ |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 7.98M | Capitalization | 4.54B |
---|---|---|---|---|---|
Net income 2024 * | -199M | Net income 2025 * | -242M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 569 x |
P/E ratio 2024 * |
-22.8
x | P/E ratio 2025 * |
-19.2
x | Employees | 106 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.45% |
1 day | +1.93% | ||
1 week | +4.79% | ||
Current month | +7.12% | ||
1 month | -0.09% | ||
3 months | -17.31% | ||
6 months | +4.66% | ||
Current year | -4.48% |
Managers | Title | Age | Since |
---|---|---|---|
James Porter
CEO | Chief Executive Officer | 48 | 16-12-31 |
Alexandra Balcom
DFI | Director of Finance/CFO | 40 | 20-12-31 |
Jeffrey Lee
CTO | Chief Tech/Sci/R&D Officer | - | 22-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 53 | 21-06-30 | |
Anna Protopapas
CHM | Chairman | 59 | 22-03-29 |
Andrew Hack
BRD | Director/Board Member | 50 | 21-05-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.12% | 0 M€ | 0.00% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.01% | 746 M€ | -.--% | - | |
0.01% | 1,487 M€ | +7.26% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 70.28 | +1.91% | 435,141 |
24-06-03 | 68.96 | +5.09% | 512,492 |
24-05-31 | 65.62 | -1.29% | 779,872 |
24-05-30 | 66.48 | +0.67% | 319,818 |
24-05-29 | 66.04 | -1.55% | 373,959 |
Delayed Quote Nasdaq, June 04, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.48% | 4.45B | |
+46.19% | 56.65B | |
-6.14% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.33% | 26.75B | |
-21.78% | 19.03B | |
-0.35% | 12.28B | |
+24.18% | 12.26B | |
+28.38% | 12.04B |
- Stock Market
- Equities
- NUVL Stock